# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-001779
Filing Date
2024-11-07
Accepted
2024-11-07 07:11:46
Documents
67
Period of Report
2024-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | zura-20240930x10q.htm iXBRL | 10-Q | 1867266
2 | EX-31.1 | zura-20240930xex31d1.htm | EX-31.1 | 14561
3 | EX-31.2 | zura-20240930xex31d2.htm | EX-31.2 | 15197
4 | EX-32.1 | zura-20240930xex32d1.htm | EX-32.1 | 8618
5 | EX-32.2 | zura-20240930xex32d2.htm | EX-32.2 | 8656
| Complete submission text file | 0001410578-24-001779.txt |  | 7497944

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | EX-101.SCH | zura-20240930.xsd | EX-101.SCH | 65661
7 | EX-101.CAL | zura-20240930_cal.xml | EX-101.CAL | 36094
8 | EX-101.DEF | zura-20240930_def.xml | EX-101.DEF | 309541
9 | EX-101.LAB | zura-20240930_lab.xml | EX-101.LAB | 536740
10 | EX-101.PRE | zura-20240930_pre.xml | EX-101.PRE | 445990
70 | EXTRACTED XBRL INSTANCE DOCUMENT | zura-20240930x10q_htm.xml | XML | 967527

Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Filer) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40598 | Film No.: 241433132
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)